We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

Other Fields Sample Clauses

Other Fields. Depending on the program request, other field locations will be charged an appropriate rate $ Varies Initial Fee shall be paid with signed user agreement before a schedule is accepted. New groups shall pay in full prior to use. Returning User groups will be billed any balances at the end of each month. It is the responsibility of the Rental groups to review all invoices and within 30 days report any discrepancies to the Recreation Department. Groups that do not make payment promptly will be billed and payments will be due all up front before the season begins until they are deemed in good standing. Additional fees must be pre-paid before field/facility usage Returned Check Fee $ 25.00 Late Payment Fees Each month for payment received more than 30 days after billing date $ 25.00 During the performance of this contract, the Consultant, Vendor and/or Service Provider, for itself, its assignees, and successors in interest (hereinafter referred to as the "contractor") agrees to comply with the following non-discrimination statutes and authorities; including but not limited to:
Other Fields. Click to indicate a player as "individual-only" (not contributing to team total score). The position for individual players is shown with an asterisk ("*") instead of an "i" to dis- tinguish it more clearly from players at position "1". current round: This value is automatically updated by the software as you enter scores # teams: The number of teams competing in the tournament (automatically filled in if you are entering full tournament scores).
Other Fields. 5.4.1. For the avoidance of doubt, MSI retains the right to exploit in any manner, including on its own or by way of licenses, the Licensed Technology outside the Field. 5.4.2. MSI and Xxxxxxxxx will negotiate in good faith licenses to MSI, for use outside the Field, of Xxxxxxxxx’x rights in any Related IP. 5.4.3. The preceding commitments to negotiate in good faith contemplate crosslicense rights or royalties to Xxxxxxxxx as part of any licenses or reductions in exclusivity.
Other Fields. During the VeriSign Post-Sale Period, upon the written request of Purchaser, Seller shall initiate proceedings or otherwise take action with respect to any infringement or misuse of the Seller Trademarks outside of the VeriSign Post-Sale Field (at Purchaser’s sole cost and expense); provided that Seller keeps Purchaser informed of the conduct and progress of such proceedings or actions within the field of the Business, and gives Purchaser the opportunity to provide reasonable input and consultation in connection therewith.
Other Fields. Xxxxxxx agrees that, upon the written request of Venoco, Xxxxxxx and Venoco shall utilize good faith efforts to negotiate and enter into an agreement whereby Xxxxxxx shall act as contract operator for other fields currently owned by Venoco in the onshore Northern California area. Such agreements shall include provision for reasonable, market rate operating fees to be paid to Xxxxxxx.
Other FieldsIf either party determines that it would like to develop products in Other Fields, it may give notice of such desire to the other party. Upon such notice, the parties shall negotiate in good faith a royalty-free cross license to the other party's Licensed Patent Rights to make, use and sell such products under reasonable terms and conditions.
Other Fields. Depending on the program request, other field locations will be charged an appropriate rate $ Varies
Other Fields. Depending on the program request, other field locations will be charged an appropriate rate $ Varies Initial Fee shall be paid with signed user agreement before a schedule is accepted. New groups shall pay in full prior to use. Returning User groups will be billed any balances at the end of each month. Groups that do not make payment promptly will be billed and payments will be due all up front before the season begins until they are deemed in good standing. Additional fees must be pre-paid before field/facility usage Returned Check Fee $ 25.00 Late Payment Fees Each month for payment received more than 30 days after billing date $ 25.00 During the performance of this contract, the Consultant, Vendor and/or Service Provider, for itself, its assignees, and successors in interest (hereinafter referred to as the "contractor") agrees to comply with the following non-discrimination statutes and authorities; including but not limited to:
Other FieldsIn the event that any field(s) outside of the Field is developed for the use of the Product (each a “New Field”), Can-Xxxx shall notify the JC regarding such New Field within reasonable time after such development. CKD shall have a right of first offer with respect to such New Field, the right of which shall be triggered on the date that such notice is given to the JC (the “New Field Notice Date”). CKD shall, within (ninety (90) days from the New Field Notice Date (the "Negotiation Period"), negotiate in good faith with Can-Xxxx in order to obtain a license to develop, have developed, register, market, have marketed, distribute, have distributed, sell, have sold, offer for sale and import and otherwise Commercialize the Product in such New Field in the Territory (the "New Field License"). In the event that the Parties are unable to agree to the terms and conditions of the New Field License during the Negotiation Period, then upon the expiry of the Negotiation Period, Can-Xxxx shall be free to grant the New Field License to any Third Party.

Related to Other Fields

  • Competing Products The provisions of Section 21 are set forth on attached Exhibit H and are incorporated in this Section 21 by this reference.

  • Licensed Products Lessee will obtain no title to Licensed Products which will at all times remain the property of the owner of the Licensed Products. A license from the owner may be required and it is Lessee's responsibility to obtain any required license before the use of the Licensed Products. Lessee agrees to treat the Licensed Products as confidential information of the owner, to observe all copyright restrictions, and not to reproduce or sell the Licensed Products.

  • Licensed Product The term “Licensed Product” shall mean any product (a) the manufacture, use, importation, sale or offer for sale of which would, in the absence of the license granted by this Agreement, infringe a Valid Claim of any of the Licensed Patent Rights, or (b) that is comprised of, utilizes or incorporates Licensed Biological Materials, or (c) that is discovered, developed or made using a Licensed Process.

  • Competitive Products Competitive Products" means products that serve the same function as, or that could be used to replace, products the Company provided to, offered to, or was in the process of developing for a present, former, or future possible customer/partner at any time during the twelve (12) months immediately preceding the last day of Participant's employment (or at any time during Participant's employment if Participant was employed for less than 12 months), with which Participant had direct responsibility for the sale or development of such products or managing those persons responsible for the sale or development of such products.

  • New Products You agree to comply with NASD Notice to Members 5-26 recommending best practices for reviewing new products.

  • Third Party Technology The Company makes use of third party technology to collect information required for traffic measurement, research, and analytics. Use of third party technology entails data collection. We therefore would like to inform clients the Company enables third parties to place or read cookies located on the browsers of users entering the Company’s domain. Said third parties may also use web beacons to collect information through advertising located on the Company’s web site. Please note that you may change your browser settings to refuse or disable Local Shared Objects and similar technologies; however, by doing so you may be disabling some of the functionality of Company’s services.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Licensed Technology (a) LICENSOR is not aware of any interference, infringement, misappropriation, or other conflict with any intellectual property rights of third parties, and LICENSOR has never received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or violation (including any claim that LICENSOR must license or refrain from using any intellectual property rights of any third party). To the knowledge of LICENSOR, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with any of the LICENSED TECHNOLOGY. (b) Exhibit A identifies each patent or registration which has been issued to LICENSOR with respect to any of the LICENSED TECHNOLOGY and identifies each pending patent application or application for registration which LICENSOR has made with respect to any of the LICENSED TECHNOLOGY. LICENSEE acknowledges that LICENSOR has previously made available to LICENSEE correct and complete copies of all such patents, registrations and applications (as amended to-date) in LICENSOR’s possession and has made available to LICENSEE correct and complete copies of all other written documentation in LICENSOR’s possession evidencing ownership and prosecution (if applicable) of each such item. (c) Exhibit A identifies each item of LICENSED TECHNOLOGY that is assigned to LICENSOR or that LICENSOR uses pursuant to license, sublicense, agreement, or permission. LICENSOR has made available to LICENSEE correct and complete copies of all such licenses, sublicenses, agreements, patent prosecution files and permissions (as amended to-date) in LICENSOR’s possession. With respect to each item of LICENSED TECHNOLOGY required to be identified in Exhibit A and to the knowledge of LICENSOR: (i) the license, sublicense, agreement, or permission covering the item is legal, valid, binding, enforceable, and in full force and effect; (ii) the license, sublicense, agreement, or permission will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the consummation of the transactions contemplated hereby; (iii) no Party to the license, sublicense, agreement, or permission is in breach or default, and no event has occurred which with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder; (iv) no party to the license, sublicense, agreement, or permission has repudiated any provision thereof; (v) the underlying item of LICENSED TECHNOLOGY is not subject to any outstanding lien or encumbrance, injunction, judgment, order, decree, ruling, or charge; (vi) no action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand is pending or is threatened which challenges the legality, validity, or enforceability of the underlying item of LICENSED TECHNOLOGY; and (vii) except as provided in Exhibit A, LICENSOR has not granted any license or similar right to the LICENSED TECHNOLOGY within the GENERAL FIELD or PARTHENOGENESIS FIELD.

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.